International Journal of Drug Regulatory Affairs

  • Year: 2021
  • Volume: 9
  • Issue: 1

A comprehensive study on regulation of herbal drugs in India, US and european union

Department of Pharmaceutical Regulatory Affairs, Hindu College of Pharmacy, Amaravathi Road, Guntur-522002, (A.P), India

Online published on 24 May, 2021.

Abstract

Over thousands of years herbal medications are been adopted by many countries. Compared to allopathic medications natural medications have less side effects and toxic reactions. In this current review we see the herbal regulations of India, U.S and Europe as per their regulatory authorities AYUSH, USFDA, European Union. This article gives an outline of herbal medications and planned to clarify the guidelines of different herbal medications (Hm’s) and administrative status of Hm’s. The interest for natural items both as medications and dietary enhancements are acquiring fast energy all through the world. As per the gauge of the World Health Organization (WHO), the interest for medicinal plants is probably going to increment from the current $14 billion per year to $5 trillion out of 2050.there are no specific herbal regulations when compared to allopathic regulations.

Keywords

AYUSH, Ayurveda, Herbal medications (HMs), IMCC (Central Council of Indian Medicine), The Drugs and Cosmetics Act, FDA, WHO, CDSCO, Regulation, Clinical trials, Herbal drugs